Complementary studies of the gastrointestinal safety of the cyclo‐oxygenase‐2‐selective inhibitor etoricoxib - Hunt, R. H.; Harper, S.; Callegari, P.; Yu, C.; Quan, H.; Evans, J.; James, C.; Bowen, B.; Rashid, F. (Alimentary pharmacology & therapeutics, 2003)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid - drug therapy; Biological and medical sciences; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors - adverse effects; Double-Blind Method; Duodenal Ulcer - chemically induced; Etoricoxib; Female; Gastrointestinal Hemorrhage - chemically induced; Humans; Ibuprofen - adverse effects; Isoenzymes - antagonists & inhibitors; Male; Medical sciences; Membrane Proteins; Middle Aged; Occult Blood; Osteoarthritis - drug therapy; Prostaglandin-Endoperoxide Synthases; Pyridines - adverse effects; Stomach Ulcer - chemically induced; Sulfones - adverse effects